People

Henry M. Xu

Henry M. Xu

Associate

Henry Xu counsels investors, founders, and management teams of emerging and established companies on transactional corporate matters, inc...

Ruth Fong Zimmerman

Ruth Fong Zimmerman

Associate

Ruth Fong Zimmerman practices in the firm’s Litigation Department. She works on a variety of matters, including complex commercial litiga...

Nicola E. Perzichilli

Nicola E. Perzichilli

Associate

Nicola Perzichilli works on a variety of corporate matters, including fund formation, corporate governance, mergers and acquisitions...

Anish  Patel

Anish Patel

Associate

Anish Patel works on a variety of litigation matters including complex commercial disputes and white-collar criminal cases. Before joinin...

Anna Maria Giblin

Anna Maria Giblin

Associate

Anna Maria Giblin represents individuals, private companies, and public entities in high-stakes complex commercial litigation, white coll...

SEE MORE >

News & Insights

July 15, 2025 | IDENTITY CRISIS: Risks and Best Practices When Doing Business With Newly Acquired Entities and Conglomerates

The ongoing trend of businesses changing hands, merging, and otherwise reshuffling their organizational charts reached a fever pitch during the zero-interest economic era of 2020-2022. Changes in a customer’s ownership, business structure, or both...

July 15, 2025 | Lowenstein Represents Green Data Center Developer Soluna in Pricing of Public Offering

Lowenstein Sandler represented Soluna Holdings, Inc., a developer of green data centers for intensive computing applications including Bitcoin mining and Artificial Intelligence (AI), in its pricing of a public offering, the gross proceeds of whic...

July 15, 2025 | Staying in Bounds: Avoiding Penalties on Estate and Gift Tax Returns

There are a dozen or more penalties that could possibly be asserted by the IRS in an estate or gift tax case. This session featuring Lowenstein Private Client Services National Chair Beth Shapiro Kaufman will discuss these penalties, when the...

July 14, 2025 | Lowenstein Represents Sonnet BioTherapeutics, Inc. in Agreement to Launch $888M HYPE Cryptocurrency Treasury Reserve Strategy

Lowenstein Sandler represented Sonnet BioTherapeutics, Inc., (NASDAQ: SONN) in a definitive agreement to enter into a business combination with Rorschach I LLC, a newly formed entity affiliated with Atlas Merchant Capital LLC, an affiliate of Para...

July 14, 2025 | One Big Beautiful Bill and Three Key Planning Notes

Last week, President Donald Trump signed into law the One Big Beautiful Bill Act (OBBBA). At nearly 900 pages in length, OBBBA’s size lives up to its name by enacting sweeping changes to estate and gift taxes, income taxes, business deductions, an...

SEE MORE >